Jeonjinbio Co., Ltd. (KOSDAQ:110020)

Jeonjinbio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	25,546	21,288	60,093	25,582	34,243	66,160
Market Cap Growth	25.61%	-64.58%	134.91%	-25.30%	-48.24%	108.38%
Enterprise Value	19,861	15,567	63,882	28,671	29,482	70,217
Last Close Price	2820.00	2350.00	8030.00	3740.00	5400.00	10950.00
PE Ratio	34.83	4.90	-	-	-	-
PS Ratio	1.74	1.11	3.83	3.28	10.65	17.11
PB Ratio	1.44	1.21	9.66	2.67	3.17	5.86
P/TBV Ratio	1.44	1.21	9.78	2.70	3.19	5.90
P/FCF Ratio	-	8.14	-	-	-	-
P/OCF Ratio	50.62	7.08	-	-	-	-
EV/Sales Ratio	1.36	0.81	4.07	3.68	9.17	18.16
EV/EBITDA Ratio	21.25	6.23	108.19	-	-	-
EV/EBIT Ratio	67.22	13.44	-	-	-	-
EV/FCF Ratio	-55.95	5.95	-	-	-	-
Debt / Equity Ratio	-	0.01	0.90	0.62	0.69	0.46
Debt / EBITDA Ratio	-	0.04	9.48	-	-	-
Debt / FCF Ratio	-	0.04	-	-	-	-
Asset Turnover	0.76	1.05	0.88	0.37	0.15	0.31
Inventory Turnover	7.29	9.95	5.83	4.52	4.02	5.04
Quick Ratio	7.51	8.47	0.54	0.26	1.11	1.24
Current Ratio	8.77	9.34	0.69	0.60	1.16	1.36
Return on Equity (ROE)	4.15%	36.40%	-81.59%	-30.58%	-19.10%	-48.21%
Return on Assets (ROA)	0.95%	3.96%	-4.37%	-9.17%	-8.70%	-9.30%
Return on Capital (ROIC)	1.04%	4.90%	-5.69%	-11.62%	-10.94%	-10.60%
Return on Capital Employed (ROCE)	1.70%	6.50%	-19.20%	-31.40%	-28.00%	-16.50%
Earnings Yield	2.85%	20.42%	-10.72%	-12.17%	-6.16%	-5.17%
FCF Yield	-1.39%	12.29%	-1.60%	-22.30%	-12.36%	-12.26%
Buyback Yield / Dilution	-9.74%	-18.07%	-10.69%	-6.14%	-27.16%	-2.69%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.